SEC Comment Letter 0000000000-23-001022 to VectivBio Holding AG (CIK 0001836379)
VectivBio Holding AG (CIK 0001836379)
Date: Feb. 1, 2023 · CIK: 0001836379 · Accession: 0000000000-23-001022
AI Filing Summary & Sentiment
File numbers found in text: 333-269450
Letter
United States securities and exchange commission logo February 1, 2023 Luca Santarelli Chief Executive Officer VectivBio Holding AG 60 Broad St., Suite 3502 New York, NY 10004 Re:VectivBio Holding AG Registration Statement on Form F-3 Filed January 27, 2023 File No. 333-269450 Dear Luca Santarelli: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Brandon Fenn
Show Raw Text
United States securities and exchange commission logo
February 1, 2023
Luca Santarelli
Chief Executive Officer
VectivBio Holding AG
60 Broad St., Suite 3502
New York, NY 10004
Re:VectivBio Holding AG
Registration Statement on Form F-3
Filed January 27, 2023
File No. 333-269450
Dear Luca Santarelli:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Brandon Fenn